Table 1 Baseline characteristics of patients
From: Radiotherapy cannot prolong overall survival of young prostate cancer patients with bone metastases
RT | Non-RT | P value | |
|---|---|---|---|
Age | 64.26 ± 4.98 | 63.96 ± 5.48 | 0.788 |
Gleason score | 7.91 ± 1.31 | 7.88 ± 1.33 | 0.913 |
PSA | 323.05 ± 529.83 | 368.14 ± 613.40 | 0.713 |
ALP | 304.32 ± 455.35 | 316.52 ± 346.32 | 0.884 |
Chemotherapy | 0.162 | ||
Yes | 9 (25.71 %) | 10 (14.49 %) | |
No | 26 (74.29 %) | 59 (85.51 %) | |
The number of bone metastases | 0.975 | ||
Single | 6 (17.14 %) | 12 (17.39 %) | |
Multiple | 29 (82.86 %) | 57 (82.61 %) | |
Regional lymph node metastasis | 0.002 | ||
Yes | 1 (2.86 %) | 20 (28.99 %) | |
No | 34 (97.14 %) | 49 (71.01 %) | |
Other organ metastasis | 0.09 | ||
Yes | 7 (20.00 %) | 25 (36.23 %) | |
No | 28 (80.00 %) | 44 (63.77 %) |